ADARx Pharmaceuticals, Inc. ADRX
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -12.14%
- 1 year
- -12.14%
- Open
- 18.10
- Prev close
- 17.85
- Mkt cap
- 1.88B
- Vol
- 542.26K
- Avg vol
- 710.16K
- EPS
- -1.16
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.30
- High
- 18.10
- Forward P/E
- -10.92
- Beta
- 0.00
- Short ratio
- 2.00
- Inst. own
- 45.56%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 18.26
- 200-d avg
- 18.26
- 1y target
- 34.25
News
-
1 week ago benzinga.com
JP Morgan Initiates Coverage On Adarx Pharmaceuticals with Overweight Rating, Announces Price Target of $38
JP Morgan analyst Tessa Romero initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Overweight rating and announces Price Target of $38.
1 week ago benzinga.com
This Restaurant Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated bullish coverage on ADRX ($32), NWSA ($35), MOD ($275), SITM ($750) and QSR ($85), with Overweight, Outperform or Buy ratings.
-
1 week ago benzinga.com
UBS Initiates Coverage On Adarx Pharmaceuticals with Buy Rating, Announces Price Target of $35
UBS analyst Michael Yee initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Buy rating and announces Price Target of $35.
-
1 week ago benzinga.com
Morgan Stanley Initiates Coverage On Adarx Pharmaceuticals with Overweight Rating, Announces Price Target of $32
Morgan Stanley analyst Michael Ulz initiates coverage on Adarx Pharmaceuticals (NASDAQ:ADRX) with a Overweight rating and announces Price Target of $32.
1 month ago globenewswire.com
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering
1 month ago gurufocus.com
First Look: Disney Layoffs, Apple Smart Home Launch, Goldman CEO Talks
Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsKen Griffin donates $3B to Carnegie Mellon: Citadel CEO Ken Griffin p
1 month ago reuters.com
ADARx Pharmaceuticals raises $446.3 million in upsized US IPO
ADARx Pharmaceuticals said on Thursday it had raised $446.3 million in an upsized US initial public offering, reflecting growing investor appetite for biotech listings.
1 month ago globenewswire.com
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering
SAN DIEGO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation siRNA therapeutics, announced today the…